RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis: prev. Amoeboid cells are stem-like and induce non-cell autonomous metastasis in vivo

Nikola Vlahov, Sander Steenbreek, Maria Laura Tognoli, Daniela Pankova, Michael Eyres, David Cano-Rodriguez, Simon Scrace, Alexander von Kriegsheim, Marianne Rots, Jacco van Rheenen, Eric O'Neill

Research output: Contribution to journalArticlepeer-review

Abstract

Activation of the GTPase RhoA increases actinomyosin contractility and a population of highly invasive amoeboid-like cells in tumours. Here we identified that the pro-metastatic oncogene RASSF1C is an activator of RhoA/ROCK signaling and amoeboid motility in cells with stem cell-like attributes. RhoA-driven amoeboid cell movement also induces the release of extracellular vesicles that promote non-cell autonomous migration and metastasis in recipient cells. Mechanistically, RASSF1C localises in the uropod like structure of fast A2-amoeboid motile cells where it activates pMLCII and supports contractility required for forward movement. In addition, amoeboid cells secret integrin-rich extracellular vesicles that support uropod attachment which are released in to the milieu upon initiation of movement. The higher level of amoeboid cells in RASSF1C+/RhoA+ tumours results in elevated A2 motility, an associated increase in vesicle release and promotion of metastasis in benign tumour cells in vivo, unravelling a common mechanism behind diverse phenotypic attributes of cancer cells.
Original languageEnglish
JournalEMBO Journal
Early online date17 Sep 2022
DOIs
Publication statusAccepted/In press - 27 Jul 2021

Fingerprint

Dive into the research topics of 'RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis: prev. Amoeboid cells are stem-like and induce non-cell autonomous metastasis in vivo'. Together they form a unique fingerprint.

Cite this